Cargando…
Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD)
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common disease that occurs all over the world. Models of care, initially accessed from the clinical point of view, must also be evaluated in terms of their economic effectiveness, as health care systems are limited. The Integrated Care Mo...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486702/ https://www.ncbi.nlm.nih.gov/pubmed/31002103 http://dx.doi.org/10.12659/MSM.913358 |
_version_ | 1783414390169534464 |
---|---|
author | Bandurska, Ewa Damps-Konstańska, Iwona Popowski, Piotr Jędrzejczyk, Tadeusz Janowiak, Piotr Świętnicka, Katarzyna Zarzeczna-Baran, Marzena Jassem, Ewa |
author_facet | Bandurska, Ewa Damps-Konstańska, Iwona Popowski, Piotr Jędrzejczyk, Tadeusz Janowiak, Piotr Świętnicka, Katarzyna Zarzeczna-Baran, Marzena Jassem, Ewa |
author_sort | Bandurska, Ewa |
collection | PubMed |
description | BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common disease that occurs all over the world. Models of care, initially accessed from the clinical point of view, must also be evaluated in terms of their economic effectiveness, as health care systems are limited. The Integrated Care Model (ICM) is a procedure dedicated to patients suffering from advanced COPD that offers home-oriented support from a multidisciplinary team. The main aim of the present study was to evaluate the cost-effectiveness of the ICM. MATERIAL/METHODS: We included 44 patients in the study (31 males, 13 females) with an average age 72 years (Me=71). Costs of care were estimated based on data received from public payer records and included general costs, COPD-related costs, and exacerbation-related costs. To evaluate cost-effectiveness, cost-effectiveness analysis (CEA) was used. The incremental cost-effectiveness ratio (ICER) was calculated based on changes in health care resources utilization and the value of costs observed in 2 consecutive 6-month periods before and after introducing ICM. RESULTS: Costs of care of all types decreased after introducing ICM. Demand for ambulatory visits changed significantly (p=0.037) together with a substantial decrease in the number of emergency department appointments and hospitalizations (p=0.033). ICER was more profitable for integrated care than for standard care when assessing costs of avoiding negative parameters such as hospitalizations (−227 EUR), exacerbations-related hospitalizations (−312 EUR), or emergency procedures (−119 EUR). CONCLUSIONS: ICM is a procedure that meets the criteria of cost-effectiveness. It allows for avoiding negative parameters such as unplanned hospitalizations with higher economic effectiveness than the standard type of care used in managing COPD. |
format | Online Article Text |
id | pubmed-6486702 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64867022019-05-03 Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD) Bandurska, Ewa Damps-Konstańska, Iwona Popowski, Piotr Jędrzejczyk, Tadeusz Janowiak, Piotr Świętnicka, Katarzyna Zarzeczna-Baran, Marzena Jassem, Ewa Med Sci Monit Clinical Research BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common disease that occurs all over the world. Models of care, initially accessed from the clinical point of view, must also be evaluated in terms of their economic effectiveness, as health care systems are limited. The Integrated Care Model (ICM) is a procedure dedicated to patients suffering from advanced COPD that offers home-oriented support from a multidisciplinary team. The main aim of the present study was to evaluate the cost-effectiveness of the ICM. MATERIAL/METHODS: We included 44 patients in the study (31 males, 13 females) with an average age 72 years (Me=71). Costs of care were estimated based on data received from public payer records and included general costs, COPD-related costs, and exacerbation-related costs. To evaluate cost-effectiveness, cost-effectiveness analysis (CEA) was used. The incremental cost-effectiveness ratio (ICER) was calculated based on changes in health care resources utilization and the value of costs observed in 2 consecutive 6-month periods before and after introducing ICM. RESULTS: Costs of care of all types decreased after introducing ICM. Demand for ambulatory visits changed significantly (p=0.037) together with a substantial decrease in the number of emergency department appointments and hospitalizations (p=0.033). ICER was more profitable for integrated care than for standard care when assessing costs of avoiding negative parameters such as hospitalizations (−227 EUR), exacerbations-related hospitalizations (−312 EUR), or emergency procedures (−119 EUR). CONCLUSIONS: ICM is a procedure that meets the criteria of cost-effectiveness. It allows for avoiding negative parameters such as unplanned hospitalizations with higher economic effectiveness than the standard type of care used in managing COPD. International Scientific Literature, Inc. 2019-04-19 /pmc/articles/PMC6486702/ /pubmed/31002103 http://dx.doi.org/10.12659/MSM.913358 Text en © Med Sci Monit, 2019 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) |
spellingShingle | Clinical Research Bandurska, Ewa Damps-Konstańska, Iwona Popowski, Piotr Jędrzejczyk, Tadeusz Janowiak, Piotr Świętnicka, Katarzyna Zarzeczna-Baran, Marzena Jassem, Ewa Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD) |
title | Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD) |
title_full | Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD) |
title_fullStr | Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD) |
title_full_unstemmed | Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD) |
title_short | Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD) |
title_sort | cost-effectiveness analysis of integrated care in management of advanced chronic obstructive pulmonary disease (copd) |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486702/ https://www.ncbi.nlm.nih.gov/pubmed/31002103 http://dx.doi.org/10.12659/MSM.913358 |
work_keys_str_mv | AT bandurskaewa costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd AT dampskonstanskaiwona costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd AT popowskipiotr costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd AT jedrzejczyktadeusz costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd AT janowiakpiotr costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd AT swietnickakatarzyna costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd AT zarzecznabaranmarzena costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd AT jassemewa costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd |